TipRanks
Verrica Pharmaceuticals (DE:1NE0)
FRANKFURT:1NE0
Germany Market

Verrica Pharmaceuticals (1NE0) Technical Analysis

1 Followers

Summary of all the Indicators

Overall Consensus
Sell
6Bullish
1Neutral
15Bearish
Technical Analysis Consensus
Buy
6Bullish
1Neutral
3Bearish
Moving Average Consensus
Strong Sell
0Bullish
0Neutral
12Bearish
Verrica Pharmaceuticals’s (1NE0) Moving Averages Convergence Divergence (MACD) indicator is -0.10, suggesting Verrica Pharmaceuticals is a Buy.
Verrica Pharmaceuticals’s (1NE0) 20-Day exponential moving average is 4.29, while Verrica Pharmaceuticals’s (1NE0) share price is €4.15, making it a Sell.
Verrica Pharmaceuticals’s (1NE0) 50-Day exponential moving average is 4.49, while Verrica Pharmaceuticals’s (1NE0) share price is €4.15, making it a Sell.

Verrica Pharmaceuticals (1NE0) Pivot Points

Sep 19, 2026, 06:47 AM
Name
S3
S2
S1
Pivot Points
R1
R2
R3
Classic
4.08
4.08
4.08
4.08
4.08
4.08
4.08
Fibonacci
4.08
4.08
4.08
4.08
4.08
4.08
4.08
Pivot points are a technical analysis tool used by traders to identify potential support and resistance levels in financial markets. Pivot points are calculated based on the previous day's high, low, and close prices, and are used to help traders identify levels at which the price may reverse or continue to trend.

Verrica Pharmaceuticals (1NE0) Moving Averages

Sep 19, 2026, 06:47 AM
Period
Simple
Exponential
MA5
4.12Sell
4.10Sell
MA10
4.30Sell
4.21Sell
MA20
4.29Sell
4.29Sell
MA50
4.51Sell
4.49Sell
MA100
4.92Sell
4.69Sell
MA200
5.25Sell
4.81Sell
Verrica Pharmaceuticals’s (1NE0) 10-Day exponential moving average is 4.21, while Verrica Pharmaceuticals’s (1NE0) share price is €4.15, making it a Sell.
Verrica Pharmaceuticals’s (1NE0) 100-Day exponential moving average is 4.69, while Verrica Pharmaceuticals’s (1NE0) share price is €4.15, making it a Sell.
Verrica Pharmaceuticals’s (1NE0) stock price is €4.15 and Verrica Pharmaceuticals’s (1NE0) 50-day simple moving average is 4.51, creating a Sell signal.
Verrica Pharmaceuticals’s (1NE0) stock price is €4.15 and Verrica Pharmaceuticals’s (1NE0) 100-day simple moving average is 4.92, creating a Sell signal.
Verrica Pharmaceuticals’s (1NE0) stock price is €4.15 and Verrica Pharmaceuticals’s (1NE0) 200-day simple moving average is 5.25, creating a Sell signal.

Verrica Pharmaceuticals (1NE0) Technical Indicators

Sep 19, 2026, 06:47 AM
Name
Value
Implied Action
RSI (14)
35.24
Neutral
STOCH (9,6)
<0.01
Buy
STOCHRSI (14)
<0.01
Buy
MACD (12,26)
-0.10
Buy
ADX (14)
13.20
Buy
Williams %R
-100.00
Buy
CCI (14)
-133.56
Buy
ATR (14)
0.12
-
Ultimate Oscillator
18.31
Sell
ROC
-6.02
Sell
Verrica Pharmaceuticals’s (1NE0) Relative Strength Index (RSI) is 35.24, creating a Neutral signal.
Verrica Pharmaceuticals’s (1NE0) Trend Strength Indicator (ADX) is 13.20, creating a Buy signal.
Verrica Pharmaceuticals’s (1NE0) Commodity Channel Index (CCI) is -133.56, creating a Buy signal.
Verrica Pharmaceuticals’s (1NE0) Price Rate of Change (ROC) is -6.02, creating a Sell signal.

FAQ

Is 1NE0 a Buy, Hold, or Sell?
Based on 1NE0’s technical indicators, 1NE0 is a Sell.
    What is 1NE0’s RSI (14)?
    1NE0’s RSI (14) is 35.24, which suggests 1NE0 is a Neutral.
      What is 1NE0’s MACD?
      1NE0’s MACD is -0.10, which suggests 1NE0 is a Buy.
        What is 1NE0’s 5-day moving average?
        1NE0’s 5-day moving average is 4.12, which suggests 1NE0 is a Sell.
          What is 1NE0’s 20-day moving average?
          1NE0 20-day moving average is 4.29, which suggests 1NE0 is a Sell.
            What is 1NE0’s 50-day moving average?
            1NE0’s 50-day moving average is 4.51, which suggests 1NE0 is a Sell.
              What is 1NE0’s 200-day moving average?
              1NE0’s 200-day moving average is 5.25, which suggests 1NE0 is a Sell.
                What is 1NE0’s Williams % R (14)?
                1NE0’s Williams % R (14) is -100.00, which suggests 1NE0 is a Buy.
                  What is 1NE0’s CCI (14)?
                  1NE0’s CCI (14) is -133.56, which suggests 1NE0 is a Buy.
                    What is the share price of Verrica Pharmaceuticals?